Siegfried Holding AG (SFZN.SW) SIX
78.15
-1(-1.26%)
Currency In CHF
- General
- Statistics
- Historical Data
- Profile
- Financials
78.15
-1(-1.26%)
Currency In CHF
Address
Untere Bruehlstrasse 4
Zofingen, 4800
Switzerland
Phone
41 62 746 1111
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
3886
First IPO Date
April 14, 1995
| Name | Title | Pay | Year Born |
| Marcel Imwinkelried | Chief Executive Officer & Chief Operating Officer Drug Products ad interim | 1.29M | 1967 |
| Beatrice Harder | Head Regulatory Affairs - Site Zofingen | 0 | N/A |
| Luca Dalla Torre | Chief Legal & Sustainability Officer | 0 | N/A |
| Reto Suter | Chief Financial Officer | 0 | 1971 |
| John Jones | Head of Operations - Malta | 0 | N/A |
| Enno Schweinberger | Head Global Quality Management DS - Zofingen | 0 | N/A |
| Peter Stierli | Head of Corporate Communications | 0 | N/A |
| Stefan Randl | Chief Scientific Officer | 0 | N/A |
| Marianne Spane | Advisor | 0 | 1962 |
| Olesia Silanteva | Chief Human Resources Officer | 0 | 1982 |
Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production. In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.